InsidersTradesSigma
Track the アンジェス株式会社 stock price and the full insider trade history of the company, a listed issuer based in Japan. Shares are listed on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, アンジェス株式会社 has logged 41 public disclosures. Market capitalisation: €18.6bn. The latest transaction was reported on 4 September 2026 (Holding update). Among the most active insiders: Cantor Fitzgerald Europe. The full history is free.
41
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,510 of 29,064 companies
16.3
score / 100
Value6
Quality26
FCF yld-38%
Earn yld-34%
EV/EBITDA·
ROE-215%
Gross mgn37%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 September 2026
Declarations41 total
ShareXTKSEDINET:S100Z0NF
0.8% of flowShareXTKSEDINET:S100XF2G
0.8% of flowShareXTKSEDINET:S100X7SU
32.6% of flowShareXTKSEDINET:S100WLRX
100.0% of flowShareXTKSEDINET:S100WK0C
ShareXTKSEDINET:S100WJK5
0.3% of flowShareXTKSEDINET:S100WDVR
0.3% of flowShareXTKSEDINET:S100WA6O
0.4% of flowShareXTKSEDINET:S100VV37
0.5% of flowShareXTKSEDINET:S100VTGP
0.5% of flowShareXTKSEDINET:S100VMZU
0.6% of flowShareXTKSEDINET:S100VG4F
0.6% of flowShareXTKSEDINET:S100VDMJ
0.7% of flowShareXTKSEDINET:S100VC7Q
0.8% of flowShareXTKSEDINET:S100V8LU
0.8% of flowShareXTKSEDINET:S100V713
1.1% of flowShareXTKSEDINET:S100UX07
1.2% of flowShareXTKSEDINET:S100UM3E
1.3% of flowShareXTKSEDINET:S100ULVH
1.5% of flowShareXTKSEDINET:S100UJEJ
1.6% of flowShareXTKSEDINET:S100UHFP
0.3% of flowShareXTKSEDINET:S100TZNB
0.3% of flowShareXTKSEDINET:S100TPF9
0.4% of flowShareXTKSEDINET:S100TNS6
0.4% of flowShareXTKSEDINET:S100TIZF
25 of 41 declarations
Acerca de アンジェス株式会社
AnGes, Inc. es una empresa centrada en el sector de la salud y farmacéutico, especializada en el desarrollo de terapias génicas y vacunas. Cotiza en el mercado XTKS.